Triple combination cancer immunotherapy improves outcomes in preclinical melanoma model
In adoptive cell transfer immunotherapy, T cells able to recognize a tumor are harvested, expanded in the laboratory, and then reintroduced to attack the tumor. However, they often do not persist long..